Signant Health has launched the Signant Health Partner Program, a significant investment the company is making to enable clinical research organizations (CROs) to better serve sponsors in the areas of Patient Data, Patient Experience, Clinical Supplies, and Endpoint Quality Solutions. 
 
As a Signant partner, CROs will gain commercial and operational advantages including exclusive commercial terms, business development support, joint marketing, clinical & scientific expertise, product training and dedicated resources for governance.
 
Chris Crucitti, Chief Commercial Officer of Signant Health said, “This program puts in place the infrastructure needed to ensure the success of our CRO partners across Signant’s solution portfolio. We will remain ever committed to the traditional support of our partners via protocol design and optimization, eCOA data collection, data quality oversight, patient engagement, eConsent and clinical supply management. However, the needs and challenges of CROs are more complex and expansive today than ever before, just as they are for the sponsors we jointly support. The time is right for us to make a landmark investment in our partners so that together we can more powerfully impact data quality and clinical trial execution. When our partners succeed, clinical research succeeds.”